Sabine Mai
Fondatore presso TELO GENOMICS CORP.
Patrimonio netto: 368 167 $ in data 31/05/2024
Profilo
Sabine Mai is the founder of Telo Genomics Corp.
which was founded in 2011.
She holds the title of Director at Telo Genomics Corp.
Dr. Mai's current jobs include being a Director at The Genomic Centre For Cancer Research & Diagnosis and a Professor at the University of Manitoba.
Dr. Mai's former job was being a Director at 3D Signatures, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TELO GENOMICS CORP.
3.94% | 08/12/2023 | 2 810 433 ( 3.94% ) | 368 167 $ | 31/05/2024 |
Posizioni attive di Sabine Mai
| Società | Posizione | Inizio |
|---|---|---|
| TELO GENOMICS CORP. | Fondatore | 25/05/2011 |
| University of Manitoba | Corporate Officer/Principal | - |
| The Genomic Centre For Cancer Research & Diagnosis | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sabine Mai
| Società | Posizione | Fine |
|---|---|---|
3D Signatures, Inc. /Old/
 3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TELO GENOMICS CORP. | Health Services |
| Aziende private | 2 |
|---|---|
3D Signatures, Inc. /Old/
3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Health Services |
| The Genomic Centre For Cancer Research & Diagnosis |
- Borsa valori
- Insiders
- Sabine Mai
